Navigation Links
First NuvaRing Lawsuits in State, Federal NuvaRing Litigations Set to Head to Trial Later This Year, Alonso Krangle LLP Reports
Date:4/16/2013

Melville, NY (PRWEB) April 16, 2013

The law firm of Alonso Krangle LLP reports that the state and federal judges overseeing thousands of NuvaRing lawsuits have rescheduled the first trials in those NuvaRing litigations. According to a Case Management Order issued by the New Jersey Superior Court, Bergen County, on March 5th, the first NuvaRing trial will not begin until June 17, 2013. (Docket No. BER-L-3081-09 MT) Court documents filed in the U.S. District Court, Eastern District of Missouri, indicate that the first trial in the federal NuvaRing litigation has been rescheduled for October 2013. (In re NuvaRing Products Liability Litigation, No. 4:08MD1964 [E.D. Mo.])
Alonso Krangle LLP, which is representing numerous women in the New Jersey NuvaRing Litigation, continues to offer FREE NuvaRing lawsuit consultations to victims of alleged NuvaRing side effects, including:

· Venous Thromboembolism (Blood Clots)
· Deep vein thrombosis
· Pulmonary embolism
· Heart attacks
· Strokes
· Wrongful death

To discuss a potential claim with one of the experienced and compassionate NuvaRing side effect lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, FightForVictims.com.

Court records indicate that well over 1,000 NuvaRing lawsuits are currently pending in the New Jersey state litigation, while several hundred have been filed in the federal NuvaRing litigation. NuvaRing lawsuits allege Merck & Co., Organon USA, Inc., and other defendants failed to provide adequate warnings regarding serious NuvaRing side effects, including a higher risk of blood clots, deep vein thrombosis and pulmonary embolism, compared to oral contraceptives. According to Alonso Krangle LLP, the first trials in both of these litigations could provide important clues as to how juries might weigh claims in similar NuvaRing lawsuits.

Since NuvaRing came on the market, a number of studies have pointed to an increased risk of blood clots and other cardiovascular problems associated with NuvaRing. For example, in October 2011, results from a large birth control study conducted by the U.S. Food & Drug Administration (FDA) revealed using NuvaRing increased the risk of blood clots, including deep vein thrombosis and pulmonary embolism, by 56% in comparison to older birth control pills. A second study, published on May 10, 2012 in the online edition of the British Medical Journal, found that NuvaRing users had a 6.5 times higher risk of experiencing a serious blood clot compared to women who did not use any form of hormonal birth control. The likelihood of experiencing a dangerous blood clot was 90% higher among users of the vaginal ring than it was for women taking combined oral contraceptives containing levonorgestrel, according to the study.
[fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf]
[bmj.com/content/344/bmj.e2990]

There is still time for women who may have been injured by NuvaRing, or their families, to file personal injury lawsuits seeking compensation for medical bills, pain and suffering, emotional distress and other damages. To discuss a potential NuvaRing lawsuit with one of the experienced and compassionate NuvaRing side effect lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical malpractice, whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City and New Jersey.

For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Contact:
Alonso Krangle LLP
445 Broad Hollow Road
Suite 205
Melville, New York 11747
Toll-FREE 1-800-403-6191
Tel: 516-350-5555
Fax: 516-350-5554

Read the full story at http://www.prweb.com/releases/2013/4/prweb10635804.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. SpineCenter Atlanta Performs First and Only Endoscopic Spine Surgery in Atlanta
2. Rescheduling of First NuvaRing Lawsuit Trials in State, Federal NuvaRing Lawsuit Litigation, Reports Wright & Schulte LLC
3. Top Miami Online Marketing Company OptFirst To Launch A New Online Marketing Platform
4. John Theurer Cancer Center hosts first Womens Oncology Conference
5. Dr. Benjamin Stong is the First Facial Plastic and Reconstructive Surgeon to Display the ABFPRS Board Certification Diplomate Logo
6. Enrollment First, Inc. and First Staff Benefits Guide Businesses Through Maze of Health Care Reform
7. For First Time, Pain Signature Spotted on Brain MRIs
8. T cell biology pioneer Allison wins first AACR honor for cancer immunology
9. Baptist Health South: First US Hospital Network to Receive Full Accreditation from ACE
10. ASH awards first Bridge Grants to sustain critical hematology research
11. First Vaginal Mesh Lawsuit Trials in Federal C.R. Bard Avaulta Mesh Litigation To Begin, Reports Wright & Schulte LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... Northern California Medical Associates ... joined their multi-specialty medical group. The dermatology practice provides general dermatologic treatment, outpatient ... to add this excellent dermatology practice to our group’s medical services,” explains NCMA ...
(Date:1/20/2017)... ... , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 Lift. Built for durability, ... on wheels, it can be wheeled out of the way and stored when not in ... "We have transformed the feedback from customers into specific enhancements and created a new product ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... Doctor ... announced it attended the January ECRM trade show to continue the marketing and distribution ... vitamin C supplement, known for providing 400 percent better absorption than traditional vitamin C ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... highest level of nutritional and bodybuilding supplements, announced it attended the January ECRM trade ... a respected bodybuilder and nutritional scientist who was determined to create a line of ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than Sin”: ... who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the ... an educator interacting with countless women who had little knowledge of the female characters ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Pharmaceuticals Inc. (NASDAQ: SGYP ), Novo Nordisk A/S ... SCMP ), and Pernix Therapeutics Holdings Inc. (NASDAQ: ... which fell on Thursday, January 19 th , 2017, finishing ... NYSE Health Care Index dropped over 0.7%, while shares of ...
(Date:1/20/2017)... Avillion LLP, a co-developer and financier of late-stage pharmaceutical product candidates, ... Chief Medical Officer. Dr Weinberg will be based in ... ... 17 years as a pharmaceutical and biotech executive with experience ranging ... of his career, he has interfaced with the US Food & ...
(Date:1/19/2017)... 19, 2017 The U.S. Food and Drug Administration ... Constipation (CIC) in adult patients. "No one ... said Julie Beitz , M.D., director of the Office ... Evaluation and Research. "With the availability of new therapies, patients ... their condition." ...
Breaking Medicine Technology: